Repeated administration of high dose levodopa enhances hydroxyl radical production in the rat striatum denervated with 6-hydroxydopamine

Neuroscience Letters

Volumn 290, Issue 1, 2000, Pages 33-36

  Ishida, Yasushi ^a   Hashiguchi, Hiroyuki ^a   Todaka, Kazunari ^a   Ishizuka, Yuta ^a   Mitsuyama, Yoshio ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

2,3 Dihydroxybenzoic acid; 6 Hydroxydopamine; Hydroxyl radical; Levodopa; Microdialysis; Salicylate trapping; Striatum

Indexed keywords

2,3 DIHYDROXYBENZOIC ACID; BENSERAZIDE; HYDROXYL RADICAL; LEVODOPA; METHAMPHETAMINE; OXIDOPAMINE; SALICYLIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DENERVATION; DOSE TIME EFFECT RELATION; FEMALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CORPUS STRIATUM; DENERVATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HYDROXYL RADICAL; INJECTIONS, INTRAPERITONEAL; LEVODOPA; OXIDOPAMINE; RATS; RATS, WISTAR;

EID: 0034683227     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)01320-3     Document Type: Article

References (19)

1. Abercrombie E.D., Bonatz A.E., Zigmond M.J. Effects of L-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats. Brain Res. 525:1990;36-44.
2. Basma A.N., Morris E.J., Nicklas W.J., Geller H.M. L-DOPA cytotoxicity to PC12 cells in culture is via its autoxidation. J. Neurochem. 64:1995;825-832.
3. Blunt S.B., Jenner P., Marsden C.D. Suppressive effect of L-DOPA on dopamine cells remaining in the ventral tegmental area of rats previously exposed to the neurotoxin 6-hydroxydopamine. Mov. Disord. 8:1993;129-133.
4. Calabresi P., Giacomini P., Centonze D., Bernardi G. Levodopa-induced dyskinesia: a pathological form of striatal plasticity? Ann. Neurol. 47:2000;S60-S69.
5. Camp D.M., Loeffler D.A., LeWitt P.A. L-DOPA does not enhance hydroxyl radical formation in the nigrostriatal dopamine system of rats with a unilateral 6-hydroxydopamine lesion. J. Neurochem. 74:2000;1229-1240.
6. Fahn S. Is levodopa toxic? Neurology. 47:1996;S184-S195.
7. Gaudin D.P., Rioux L., Bédard P.J. Fetal dopamine neuron transplants prevent behavioral supersensitivity induced by repeated administration of L-DOPA in the rat. Brain Res. 506:1990;166-168.
8. Han S.-K., Mytilineou C., Cohen G. L-DOPA up-regulates glutathione and protects mesencephalic cultures against oxidative stress. J. Neurochem. 66:1996;501-510.
9. Henry B., Crossman A.R., Brotchie M. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat. Exp. Neurol. 155:1999;204-220.
10. Ishida Y., Todaka K., Kuwahara I., Hashiguchi H., Ishizuka Y., Nakane H., Mitsuyama Y. Peripherally administered tetrahydrobiopterin increases in vivo tryptophan hydroxylase activity in the striatum after transplantation of fetal ventral mesencephalon in 6-hydroxydopamine lesioned rats. Neurosci. Lett. 253:1998;45-48.
11. Lancelot E., Lecanu L., Revaud M., Boulu R.G., Plotkine M., Callebert J. Glutamate induces hydroxyl radical formation in vivo via activation of nitric oxide synthase in Sprague-Dawley rats. Neurosci. Lett. 242:1998;131-134.
12. Maeda T., Cheng N., Kume T., Kaneko S., Kouchiyama H., Akaike A., Ueda M., Satoh M., Goshima Y., Misu Y. L-DOPA neurotoxicity is mediated by glutamate release in cultured rat striatal neurons. Brain Res. 771:1997;159-162.
13. Mena M.A., Casarejos M.J., Carazo A., Paino C.L., Yebenes J.G. Glia protect fetal midbrain dopamine neurons in culture from L-DOPA toxicity through multiple mechanisms. J. Neural. Transm. 104:1997;317-328.
14. Mytilineou C., Han S.-K., Cohen G. Toxic and protective effects of L-DOPA on mesencephalic cell cultures. J. Neurochem. 61:1993;1470-1478.
15. Obata T., Yamanaka Y. Protective effect of carbidopa on hydroxyl radical generation in the rat striatum by dopamine. Neurosci. Lett. 221:1996;13-16.
16. Ogawa N., Asanuma M., Kondo Y., Kawada Y., Yamamoto M., Mori A. Differential effects of chronic L-DOPA treatment on lipid peroxidation in the mouse brain with or without pretreatment with 6-hydroxydopamine. Neurosci. Lett. 171:1994;55-58.
17. Smith T.S., Parker W.D. Jr, Bennett J.P. Jr. L-DOPA increases nigral production of hydroxyl radicals in vivo: potential L-DOPA toxicity? NeuroReport. 5:1994;1009-1011.
18. Spina M.B., Cohen G. Dopamine turnover and glutathione oxidation: implications for Parkinson's disease. Proc. Natl. Acad. Sci. USA. 86:1989;1398-1400.
19. Zigmond M.J., Hastings T.G., Abercrombie E.D. Neurochemical responses to 6-hydroxydopamine and L-DOPA therapy: implications for Parkinson's disease. Ann. N.Y. Acad. Sci. 648:1992;71-86.